Literature DB >> 33107690

Transition Metal-Free Synthesis of Carbamates Using CO2 as the Carbon Source.

Waldemar Schilling1, Shoubhik Das2.   

Abstract

Utilization of carbon dioxide as a C1 synthon is highly attractive for the synthesis of valuable chemicals. However, activation of CO2 is highly challenging, owing to its thermodynamic stability and kinetic inertness. With this in mind, several strategies have been developed for the generation of carbon-heteroatom bonds. Among these, formation of C-N bonds is highly attractive, especially, when carbamates can be synthesized directly from CO2 . This Minireview focuses on transition metal-free approaches for the fixation of CO2 to generate carbamates for the production of fine chemicals and pharmaceuticals. Within the past decade, transition metal-free approaches have gained increasing attention, but traditional reviews have rarely focused on these approaches. Direct comparisons between such methods have been even more scarce. This Minireview seeks to address this discrepancy.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  carbamates; carbon dioxide; green chemistry; organocatalysis; pharmaceuticals

Year:  2020        PMID: 33107690     DOI: 10.1002/cssc.202002073

Source DB:  PubMed          Journal:  ChemSusChem        ISSN: 1864-5631            Impact factor:   8.928


  3 in total

1.  How the Lewis Base F- Catalyzes the 1,3-Dipolar Cycloaddition between Carbon Dioxide and Nitrilimines.

Authors:  Dennis Svatunek; Thomas Hansen; Kendall N Houk; Trevor A Hamlin
Journal:  J Org Chem       Date:  2021-02-12       Impact factor: 4.354

2.  Oxovanadium(V)-Catalyzed Synthesis of Ureas from Disilylamines and Carbon Dioxide under Ambient Pressure.

Authors:  Takanari Matsutani; Kotaro Aoyama; Toshiyuki Moriuchi
Journal:  ACS Omega       Date:  2022-03-15

3.  Oxovanadium(v)-catalyzed amination of carbon dioxide under ambient pressure for the synthesis of ureas.

Authors:  Toshiyuki Moriuchi; Takashi Sakuramoto; Takanari Matsutani; Ryota Kawai; Yosuke Donaka; Mamoru Tobisu; Toshikazu Hirao
Journal:  RSC Adv       Date:  2021-08-09       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.